Jazz Pharmaceuticals plc (JAZZ) : Net money flow in Jazz Pharmaceuticals plc (JAZZ) was negative ($17.55 million) and the inflow of money on uptick was $18.69 million, whereas, the outflow of money on downticks amounted to $36.23 million on Monday. The traders used every opportunity of price strength in the stock to sell their positions, hence, the total uptick to downtick ratio was 0.52. The block trades show that the large investors, were aggressive sellers in the stock. On the other hand, the total value of block trades done on downticks was $15.48 million. The money flow in block trades was negative ($15.48). Jazz Pharmaceuticals plc (JAZZ) gained $1.42 cent during the day and reached $137.98, a gain of 1.04% over the previous day.
Jazz Pharmaceuticals Public Limited Company has lost 7.41% in the last five trading days and dropped 3.09% in the last 4 weeks. Jazz Pharmaceuticals Public Limited Company has dropped 7.37% during the last 3-month period . Year-to-Date the stock performance stands at -1.84%.
Jazz Pharmaceuticals plc (NASDAQ:JAZZ): During Mondays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $136.45 and $136.45 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $138.88. The buying momentum continued till the end and the stock did not give up its gains. It closed at $137.98, notching a gain of 1.04% for the day. The total traded volume was 634,018 . The stock had closed at $136.56 on the previous day.
In a related news, Smith Karen L., officer (Global Head of R&D and CMO) of Jazz Pharmaceuticals Plc, had purchased 608 shares on August 12, 2016. The total value of the transaction was $83,405. The information was disclosed with the SEC in a Form 4 Filing. The information is based on open market trades at the market prices.Option exercises are not covered.